Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Frequently Asked Questions

General

What is the purpose of this funding opportunity?
CDC announces the competitive availability of fiscal year 2019 funds to implement a capacity building assistance (CBA) program to strengthen the capacity and improve the performance of the nation’s HIV prevention workforce. This notice of funding opportunity (NOFO) supports a CBA Provider Network (CPN) to implement the following four program components: 1) national training; 2) regional TA; 3) continuous quality improvement and sustainability for CBOs; and 4) marketing and administrative support for the CPN. These components prioritize building individual competencies and technical expertise, strengthening organizational capacities, and enabling supportive structural environments for the HIV prevention workforce to optimally plan, integrate, implement, and sustain comprehensive HIV prevention programs and services. This NOFO promotes and supports national prevention goals, the HIV care continuum, and CDC’s High Impact HIV Prevention (HIP) approach.

What is the overall approach of this funding opportunity?
Available funding and required activities are categorized as follows:

Component 1: National Training
Track A. Electronic Learning (ELearning) Training Center
Track B. Classroom Learning Training Center

Component 2: Regional Technical Assistance
Track A. Clinical HIV Testing and Prevention for Persons with HIV
Track B. Nonclinical HIV Testing and Prevention for HIV-Negative Persons
Track C. Integrated HIV Activities and Structural Interventions

Component 3: Continuous Quality Improvement and Sustainability for CBOs

Component 4: Marketing and Administrative Support for the CPN

How does this approach differ from the current CBA program (PS14-1403)?

Component 1: National Training
There is a separation of web-based and classroom-based training. Under Track A: eLearning Training Center, one CBA provider will be responsible for developing and/or delivering all existing and new web-based training. Under Track B: Classroom Learning Training Center, one CBA provider will be responsible for developing and/or delivering all existing and new classroom-based training. The two CBA providers will share responsibility for the collaborative development and/or delivery of existing and new training with a blended learning format. Additionally, national training participants will receive a follow-up activity to determine implementation status and challenges. Identified needs for technical assistance will be referred to
Component 2: Regional Technical Assistance.

Component 2: Regional Technical Assistance
Technical assistance will be tailored and delivered to meet the capacity building needs within four geographic regions (i.e., Northeast, South, Midwest, and West). Each region will have a team of three CBA providers; one for each of the following: Track A. Clinical HIV Testing and Prevention for Persons with HIV, Track B. Nonclinical HIV Testing and Prevention for HIV-Negative Persons, and Track C. Integrated HIV Activities and Structural Interventions. These teams of CBA providers will be physically located within their respective geographic regions identified for TA delivery. CBA providers will collaboratively develop and implement jurisdictional CBA plans for CDC-funded health departments and CBOs within their geographic regions. Identified needs for national training will be referred to Component 1: National Training.

Component 3: Continuous Quality Improvement and Sustainability for CBOs
A new distance-learning program to further support senior and mid-level HIV prevention program managers within CDC directly funded CBOs seeking to improve the quality of their HIV prevention programs and services and/or sustainability of their organizations.

Component 4: Marketing and Administrative Support for the CBA Provider Network (CPN)
Renewed focus on marketing of the CBA program and administrative support for communication, coordination and collaboration among the CPN.

What are the measurable outcomes for this funding opportunity?
This program is expected to demonstrate measurable progress toward addressing short-term and intermediate outcomes that appear bolded in the logic model and as described in the section entitled “CDC Evaluation and Performance Measurement Strategy” further describes the outputs and indicators that quantify program outcomes. A summary of short-term and intermediate outcomes to be measured and reported by funding recipients is as follows:

Component 1: National Training
Short-term Outcomes:

Track A: Electronic Learning (eLearning) Training Center

  • Increased CDC-approved trainings available in eLearning or blended learning formats
  • Increased organizations implementing CDC-supported HIP interventions and public health strategies

Track B: Classroom Learning Training Center

  • Increased CDC-approved trainings available in classroom and blended learning formats
  • Increased organizations implementing CDC-supported HIP interventions and public health strategies
  • Increased national trainers with the capacity to deliver CDC-approved classroom or blended learning trainings
  • Increased health departments conducting HIP intervention and public health strategy trainings using CDC-approved curricula
  • Continued trainer capacity to deliver all new and existing CDC-approved classroom or blended learning training curricula

Intermediate Outcomes:

  • Improved sustainability of HIP interventions and public health strategies being implemented by CDC-funded programs
  • Improved delivery of HIV testing services among priority populations
  • Increased identification of newly and previously diagnosed HIV infections
  • Improved delivery of HIV prevention services to persons with HIV (PWH) and HIV-negative persons
  • Improved linkage to and retention in HIV medical care for PWH
  • Improved linkage to essential supportive services for PWH and HIV-negative persons

Component 2: Regional Technical Assistance
Short-term Outcomes:
Track A: Clinical HIV Testing and Prevention for Persons with HIV

  • Strengthened capacity of CDC-funded programs to implement clinical HIV testing
  • Strengthened capacity of CDC-funded programs to implement services to prevent new HIV infections and reduce transmission of HIV

Track B: Nonclinical HIV Testing and Prevention for HIV-Negative Persons

  • Strengthened capacity of CDC-funded programs to implement nonclinical HIV testing
  • Strengthened capacity of CDC-funded programs to implement services to prevent new HIV infections and reduce transmission of HIV

Track C: Integrated HIV Activities and Structural Interventions

  • Strengthened capacity of CDC-funded programs for HIV activities integration
  • Strengthened capacity of CDC-funded programs to implement structural interventions

Intermediate Outcomes:
Track A: Clinical HIV Testing and Prevention for Persons with HIV

  • Improved delivery of clinical HIV testing services
  • Increased identification of newly and previously diagnosed HIV infections
  • Improved delivery of HIV prevention services to PWH
  • Improved linkage to and retention in HIV medical care for PWH
  • Improved linkage to essential supportive services for PWH

Track B: Nonclinical HIV Testing and Prevention for HIV-Negative Persons

  • Improved delivery of nonclinical HIV testing services among priority populations
  • Increased identification of newly and previously diagnosed HIV infections
  • Improved delivery of HIV prevention services for HIV-negative persons
  • Improved linkage to essential supportive services for HIV-negative persons

Track C: Integrated HIV Activities and Structural Interventions

  • Increased identification of newly and previously diagnosed HIV infections
  • Improved linkage to HIV prevention services for PWH and HIV-negative persons
  • Improved linkage to and retention in HIV medical care for PWH
  • Improved linkage to essential supportive services for PWH and HIV-negative persons

Component 3: Continuous Quality Improvement and Sustainability for Community-Based Organizations
Short-term Outcome:

  • Improved capacity of CDC-funded CBOs to plan, manage, and sustain HIV prevention programs and services and to reduce HIV-related disparities

Component 4: Marketing and Administrative Support for CBA Provider Network (CPN)
Short-term Outcomes:

  • Increased HIV prevention workforce knowledge of CBA services and resources
  • Increased HIV prevention workforce use of CBA services and resources

What are key dates for this funding opportunity?
Publication: September 12, 2019
Letters of Intent Due: October 12, 2019
Applications Due: November 12, 2019
Announcement Date: No later than April 1, 2019
Award Date: April 1, 2019
Project Period: April 1, 2019 – March 31, 2024

Where can I obtain the application package for this funding opportunity?
Visit www.grants.gov to view and download the application package for this funding opportunity. Additional resources regarding this funding opportunity are available at https://www.cdc.gov/hiv/funding/announcements/ps19-1904/index.html.

What technical assistance (TA) is available for applicants?
During the 60-day application phase (September 12, 2019 – November 12, 2019), applicants may access TA through the following:

  • PS19-1904 website – updates, TA webinars information, FAQs, and additional resources at https://www.cdc.gov/hiv/funding/announcements/ps19-1904/index.html; and
  • an inquiry email box at CBANOFO@cdc.gov and voicemail box at (404) 718-3180. CDC will respond within 3 business days. As appropriate, applicant questions and CDC responses will be regularly posted to Frequently Asked Questions on the website.

Eligibility

What are the eligibility requirements for this funding opportunity?
Eligibility Information

Can an organization currently receiving federal funding to provide capacity building assistance (e.g., training or technical assistance) apply for this funding opportunity?
Yes. Any organization that meets all eligibility requirements can apply for funding opportunity.

Can a state, tribal, or local health department apply for this funding opportunity?
Yes. Any organization that meets all eligibility requirements can apply for funding opportunity.

Can an organization use funding to deliver HIV prevention programs and/or services to clients?
No. This program will support building the capacity of organizations to improve their delivery of HIV prevention programs and/or services.

Can an organization seeking to profit (e.g., fees to access informational materials, deliver training or technical assistance, or develop new or existing products) apply for this funding opportunity?

No. The funding recipient will be required to deliver free training and TA products and services.


Application

What should applicant know about the requested letter of intent (LOI)?
Letter of Intent

Is there an application checklist to ensure that I am submitting all required materials?
Yes. Application Submission Checklist

How much funding is available under this funding opportunity?
Attachment B: PS19-1904 Funding Table

What is the funding for which an organization can apply?
Applicants may only apply for one of the following components:

Component 1: National Training
Select one track:
Track A. Electronic Learning (ELearning) Training Center
Track B. Classroom Learning Training Center

Component 2: Regional Technical Assistance
Select one track:
Track A. Clinical HIV Testing and Prevention for Persons with HIV
Track B. Nonclinical HIV Testing and Prevention for HIV-Negative Persons
Track C. Integrated HIV Activities and Structural Interventions

AND

Select one region:

West: Region comprised of AK, AZ, CA, CO, HI, ID, MT, NM, NV, OR, UT, WA, WY and the Pacific Island Jurisdictions of American Samoa, Guam, Marshall Islands, Micronesia, Northern Mariana Islands, and Palau with approximately 33 CDC-funded programs.

Midwest: Region comprised of IA, IL, IN, KS, MI, MN, MO, ND, NE, OH, SD, and WI with approximately 27 CDC-funded programs.

Northeast: Region comprised of CT, MA, ME, VT, NH, NJ, NY, PA, RI, and the territories of Puerto Rico and US Virgin Islands with approximately 47 CDC-funded programs

South: Region comprised of AL, AR, DC, DE, FL, GA, KY, LA, MD, MS, NC, OK, SC, TN, TX, VA, and WV and with approximately 57 CDC-funded programs.

Component 3: Continuous Quality Improvement and Sustainability for CBOs

Component 4: Marketing and Administrative Support for the CPN

For Component 2: Regional Technical Assistance, why must applicants select a geographic region in which they have an established operating unit or office for implementation of a regional TA program?

This requirement promotes and supports TA providers and services that are acceptable, available, and accessible to CDC-funded programs and their local partners within a geographic region. In addition, this approach can reduce the travel costs associated with regional TA delivery, thereby further maximizing the use and impact of federal funding within each region.

What is the target population for this funding opportunity?

For purposes of this funding opportunity, the target population is comprised of the interdisciplinary HIV prevention workforce (e.g., professional, technical, clinical, and managerial staff) within current and future CDC-funded state and local health departments and CBOs and their local partner organizations (e.g., healthcare organizations and non-CDC-funded CBOs). The HIV prevention workforce plans, integrates, implements, and sustains comprehensive HIV prevention programs and services for persons with and populations at greatest risk of HIV infection. Successful applicants must provide CBA services in a manner that is available, accessible, and acceptable to the HIV prevention workforce regardless of age, race, ethnicity, gender identity, sexual orientation, geography, socioeconomic status, disability status, primary language, health literacy, and other relevant social dimensions.

How does this funding opportunity address health disparities?

Health equity is a desirable goal that entails the provision of optimal health for all despite social or economic disadvantage. HIV-related health disparities are associated with social determinants that influence the health of populations most disproportionately affected by HIV. Social determinants of health also affect disparities in viral hepatitis, STDs, and TB. For example, environmental factors such as unstable housing conditions, high-risk sexual and social networks, and poor social support are associated with increased risk for HIV, viral hepatitis, STDs, and TB. This program supports efforts to reduce health disparities and promote health equity, particularly among persons with and populations at greatest risk of HIV infection, including blacks/African Americans; Hispanics/Latinos; all races/ethnicities of gay, bisexual, and other men who have sex with men (MSM); people who inject drugs (PWID); and transgender persons. Funding recipients should use existing relevant data as well as culturally and linguistically appropriate HIV prevention messages, strategies, and interventions to accurately focus required CBA program activities for addressing social determinants of health, reducing health disparities, and promoting health equity among populations served by CDC-funded health departments and CBOs and their local partners. Details of a health equity strategy and approach are outlined in the NCHHSTP Social Determinants of Health White Paper (http://www.cdc.gov/socialdeterminants/docs/SDH-White-Paper-2010.pdf).

What should an applicant know about submitting documentation of current or proposed collaborations?

Memorandums of Agreement (MOA), Memorandums of Understanding (MOU), letters of commitment, or service agreements may formally document the scope of work, intensity, and duration of collaborations with external partners. Each document should thoroughly describe the proposed collaboration and specific activities, which parties are responsible for what, and the intended outcomes and benefits for the overall CBA program.

These documents should be on official letterhead, signed by all collaborating parties, and electronically submitted with your application. Do not mail, email, or fax these documents.  Please minimize the number of submitted pages by only providing documents that directly address your execution of the proposed program.

What is the process for the review and selection of applications for this funding opportunity?
After You Apply

Can this funding opportunity be used to support research?

PS19-1904 is only for non-research domestic activities supported by CDC. If research is proposed, the application will not be considered. Research for this purpose is defined at http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf.

TOP